Camarillo’s Micronor to debut signal conditioner at trade show
Camarillo-based Micronor will debut a new single channel signal conditioner created in collaboration with German company Optocon AG, at the SPIE Photonics West from Jan. 28-Feb 2. The product, designated FOTEMP1-OEM-MNT, integrates fiber optic temperature sensing into industrial control systems, medical instrumentation or other designs, to provide temperature monitoring in challenging environments. The technology could Read More →
Thousand Oaks makes interim city manager permanent
After serving as interim city manager for Thousand Oaks since July 5, 2016, Andrew Powers was brought on permanently Jan. 10 in a special meeting of the Thousand Oaks City Council. Powers had previously served as assistant city manager and in community and media relations roles for Ventura and Raleigh, N.C. He received his bachelor’s Read More →
Limoneira reports strong revenue growth
Santa Paula agribusiness Limoneira reported increased revenues for the fourth quarter and fiscal year 2016, exceeding its guidance with an operating income of $9.2 million. Net income applicable to common stock, after preferred dividends, was $7.4 million for the year, or 52 cents per common share, up from $6.4 million in 2015. The company had announced expectations of operating Read More →
Amgen updates agreement with DaVita for dialysis treatment
Thousand Oaks biotech company Amgen entered into a six-year supply agreement with DaVita for dialysis treatments, the company announced on Jan. 9. Under the terms of the new agreement, Amgen will supply DaVita with Epogen and Aranesp for agents to stimulate red blood cells in dialysis treatment in the United States and Puerto Rico. The Read More →
Amgen partners with Immatics Biotechnologies to develop cancer drugs
Thousand Oaks biotech company Amgen formed a potential $500 million partnership with Immatics Biotechnologies GmbH to research and develop next-generation, T-cell engaging bispecific immunotherapies targeting multiple cancers, the company announced on Jan. 9. Under the terms of the agreement, Immatics will receive $30 million upfront and can receive more than $500 million in development, regulatory Read More →